XML 132 R9.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
 3 Months Ended 12 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Dec. 31, 2023
Dec. 31, 2022
Grant revenue $ 2,347,250 $ 1,407,868 $ 7,144,872 $ 0
Operating expenses:        
Research and development 2,814,258 1,833,274 8,438,499 1,336,469
General and administrative 2,127,930 1,000,913 6,519,268 2,139,065
Total operating expenses 4,942,188 2,834,187 14,957,767 3,475,534
Loss from operations (2,594,938) (1,426,319) (7,812,895) (3,475,534)
Other income (expense):        
Other income (expense) (30) 856,579 5,421,592 (2,389,152)
Interest income 80,633 35,404 219,430 62,226
Total other income (expense) 80,603 891,983 5,641,022 (2,327,513)
Net income (loss) $ (2,514,335) $ (534,336) $ (2,171,873) $ (5,803,047)
Earnings Per Share [Abstract]        
Net income (loss) per share of common stock - basic (in dollars per share) $ (0.41) $ (1.03) $ (0.82) $ (11.2)
Weighted average shares outstanding - basic (in shares) 6,170,501 518,140 2,661,416 518,140